127 related articles for article (PubMed ID: 18607342)
1. Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.
Rangarajan V; Juul SE
Pediatr Neurol; 2014 Oct; 51(4):481-8. PubMed ID: 25266611
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin: still on the neuroprotection road.
Subirós N; Del Barco DG; Coro-Antich RM
Ther Adv Neurol Disord; 2012 May; 5(3):161-73. PubMed ID: 22590480
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Delivery of Erythropoietin Across the Blood-Brain Barrier for Neuroprotection against Ischemic Neuronal Injury.
Zhang F; Xing J; Liou AK; Wang S; Gan Y; Luo Y; Ji X; Stetler RA; Chen J; Cao G
Transl Stroke Res; 2010 Jun; 1(2):113-21. PubMed ID: 20577577
[TBL] [Abstract][Full Text] [Related]
4. Melatonin and Ischemic Stroke: Mechanistic Roles and Action.
Andrabi SS; Parvez S; Tabassum H
Adv Pharmacol Sci; 2015; 2015():384750. PubMed ID: 26435711
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective and neuroregenerative drugs after severe traumatic brain injury : A narrative review from a clinical perspective.
Grgac I; Herzer G; Voelckel WG; Secades JJ; Trimmel H
Wien Klin Wochenschr; 2024 May; ():. PubMed ID: 38748062
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic and bioinformatics analysis of the mechanism by which erythropoietin promotes recovery from traumatic brain injury in mice.
Tan W; Ma J; Fu J; Wu B; Zhu Z; Huang X; Du M; Wu C; Balawi E; Zhou Q; Zhang J; Liao Z
Neural Regen Res; 2024 Jan; 19(1):171-179. PubMed ID: 37488864
[TBL] [Abstract][Full Text] [Related]
7. Ameliorative effects of
Jalali J; Ghasemzadeh Rahbardar M
Iran J Basic Med Sci; 2023 Jan; 26(1):2-12. PubMed ID: 36594059
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant erythropoietin improves motor function in rats with spinal cord compression-induced cervical myelopathy.
Tanaka T; Murata H; Miyazaki R; Yoshizumi T; Sato M; Ohtake M; Tateishi K; Kim P; Yamamoto T
PLoS One; 2019; 14(12):e0214351. PubMed ID: 31821342
[TBL] [Abstract][Full Text] [Related]
9. Notch signaling in cerebrovascular diseases (Review).
Cai Z; Zhao B; Deng Y; Shangguan S; Zhou F; Zhou W; Li X; Li Y; Chen G
Mol Med Rep; 2016 Oct; 14(4):2883-98. PubMed ID: 27574001
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin Inhibits the Increase of Pulmonary Labile Zinc and the Expression of Inflammatory Mediators Following Subarachnoid Hemorrhage in Rats.
Zhou Y; Zhao X; Tang Y; Zhu L; Jiang J; Lu X
Neurocrit Care; 2016 Jun; 24(3):472-80. PubMed ID: 26627226
[TBL] [Abstract][Full Text] [Related]
11. What's New in Traumatic Brain Injury: Update on Tracking, Monitoring and Treatment.
Reis C; Wang Y; Akyol O; Ho WM; Ii RA; Stier G; Martin R; Zhang JH
Int J Mol Sci; 2015 May; 16(6):11903-65. PubMed ID: 26016501
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4.
Chu H; Ding H; Tang Y; Dong Q
Lab Invest; 2014 Sep; 94(9):1042-53. PubMed ID: 24978642
[TBL] [Abstract][Full Text] [Related]
13. Acute Statin Treatment Improves Recovery after Experimental Intracerebral Hemorrhage.
Yang D; Zhang J; Han Y; James E; Chopp M; Seyfried DM
World J Neurosci; 2013 May; 3(2):69-75. PubMed ID: 23837132
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin mediates neurobehavioral recovery and neurovascular remodeling following traumatic brain injury in rats by increasing expression of vascular endothelial growth factor.
Xiong Y; Zhang Y; Mahmood A; Meng Y; Qu C; Chopp M
Transl Stroke Res; 2011 Dec; 2(4):619-32. PubMed ID: 22707988
[TBL] [Abstract][Full Text] [Related]
15. Dose effect evaluation and therapeutic window of the neuro-EPO nasal application for the treatment of the focal ischemia model in the Mongolian gerbil.
Teste IS; Tamos YM; Cruz YR; Cernada AM; Rodríguez JC; Martínez NS; Antich RM; González-Quevedo A; Rodríguez JC
ScientificWorldJournal; 2012; 2012():607498. PubMed ID: 22701364
[TBL] [Abstract][Full Text] [Related]
16. Impact of inhibition of erythropoietin treatment-mediated neurogenesis in the dentate gyrus of the hippocampus on restoration of spatial learning after traumatic brain injury.
Zhang Y; Chopp M; Mahmood A; Meng Y; Qu C; Xiong Y
Exp Neurol; 2012 May; 235(1):336-44. PubMed ID: 22414310
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats.
Meng Y; Xiong Y; Mahmood A; Zhang Y; Qu C; Chopp M
J Neurosurg; 2011 Sep; 115(3):550-60. PubMed ID: 21495821
[TBL] [Abstract][Full Text] [Related]
18. Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance.
Bencherif M
Acta Pharmacol Sin; 2009 Jun; 30(6):702-14. PubMed ID: 19498416
[TBL] [Abstract][Full Text] [Related]
19. The use of erythtropoietin in cerebral diseases.
Cotena S; Piazza O; Tufano R
Panminerva Med; 2008 Jun; 50(2):185-92. PubMed ID: 18607342
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
